Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
The FDA approved Novartis' revolutionary CAR-T cell leukemia therapy, which uses patients' genetically modified immune cells to fight the disease — at the cost of $475,000 per treatment, according to STAT.
The Food and Drug Administration this month granted breakthrough designation to a Santa Cruz, Calif.-based nonprofit's MDMA therapy for post-traumatic stress disorder.
The Food and Drug Administration on Tuesday approved Rempex Pharmaceuticals' antibacterial drug Vabomere.
The FDA on Tuesday approved Chemo Research's Chagas drug for use in children ages 2 to 12.
Abbott Laboratories on Tuesday released a software update to boost cybersecurity protection for its pacemakers, reports StarTribune.
Food suppliers like Nestle, Unilever and Walmart will use IBM's blockchain network to reduce food contamination, according to CNBC.
Reducing inflammation — independent of lowering cholesterol — can reduce the risk of heart attacks, according to research sponsored by Novartis and presented Sunday at the European Society of Cardiology in Barcelona. The clinical trial results were also published in…
The Food and Drug Administration on Monday approved Abbott Laboratories' HeartMate 3 Left Ventricular Assist System, according to StarTribune.
AstraZeneca will partner with Takeda Pharmaceuticals to co-develop an experimental drug to treat Parkinson's disease.
The FDA is taking aim at stem cell clinics using unproven and potentially hazardous treatments.